Cytek Biosciences, Inc. (CTKB) stock
CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)
Close on Nov 17, 2026Market cap $740.91MP/E –Yield –
Cytek Biosciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Cytek Biosciences's EV/EBITDA was 695.6× on Jan 31, 2023, against 95.6× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 695.6× | +134.5 |
| 2022 | Dec 30, 2022 | 561.1× | +451.2 |
| 2021 | Dec 31, 2021 | 109.9× | – |
See a number that looks wrong?